High sacrectomy for locally recurrent rectal cancer

Can long-term survival be achieved?

Eric Dozois, A. Privitera, S. D. Holubar, J. F. Aldrete, F. H. Sim, P. S. Rose, M. F. Walsh, T. C. Bower, B. C. Leibovich, Heidi Nelson, David Larson

Research output: Contribution to journalArticle

52 Citations (Scopus)

Abstract

Background: Locally recurrent rectal cancer involving the upper sacrum is generally considered a contra-indication to curative surgery. The aim of this study was to determine if a survival benefit was seen in patients undergoing high sacrectomy. Methods All patients with locally recurrent rectal cancer involving the sacrum above the 3rd sacral body between 1999 and 2007 were retrospectively reviewed. Kaplan-Meier survival analysis was performed. Results Nine patients were identified with a median age of 63 years. The proximal extent of sacral resection was through S2 (n=6), S1 (n=2), and L5-S1 (n=1). All patients had R0 negative-margin resection. Median operative time was 13.7 hr, and median operative blood transfusion was 3.7 L. Thirty-day mortality was nil. Postoperative complications requiring surgical intervention occurred in three patients. Local re-recurrence in the pelvis occurred in one patient. The overall median survival was 31 months (range, 2-39 months). Three patients still alive are free of disease after 40, 76, and 101 months, respectively. Ultimately, all deaths were due to metastatic disease. Conclusions: High sacrectomy that achieves clear margins in patients with recurrent rectal cancer is safe and feasible. A majority will die of metastatic disease, but long-term survival may be possible in some patients.

Original languageEnglish (US)
Pages (from-to)105-109
Number of pages5
JournalJournal of Surgical Oncology
Volume103
Issue number2
DOIs
StatePublished - Feb 2011

Fingerprint

Rectal Neoplasms
Survival
Sacrum
Kaplan-Meier Estimate
Survival Analysis
Operative Time
Pelvis
Blood Transfusion
Recurrence
Mortality

Keywords

  • long-term survival
  • recurrent rectal cancer
  • sacrectomy

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

High sacrectomy for locally recurrent rectal cancer : Can long-term survival be achieved? / Dozois, Eric; Privitera, A.; Holubar, S. D.; Aldrete, J. F.; Sim, F. H.; Rose, P. S.; Walsh, M. F.; Bower, T. C.; Leibovich, B. C.; Nelson, Heidi; Larson, David.

In: Journal of Surgical Oncology, Vol. 103, No. 2, 02.2011, p. 105-109.

Research output: Contribution to journalArticle

Dozois, E, Privitera, A, Holubar, SD, Aldrete, JF, Sim, FH, Rose, PS, Walsh, MF, Bower, TC, Leibovich, BC, Nelson, H & Larson, D 2011, 'High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved?', Journal of Surgical Oncology, vol. 103, no. 2, pp. 105-109. https://doi.org/10.1002/jso.21774
Dozois, Eric ; Privitera, A. ; Holubar, S. D. ; Aldrete, J. F. ; Sim, F. H. ; Rose, P. S. ; Walsh, M. F. ; Bower, T. C. ; Leibovich, B. C. ; Nelson, Heidi ; Larson, David. / High sacrectomy for locally recurrent rectal cancer : Can long-term survival be achieved?. In: Journal of Surgical Oncology. 2011 ; Vol. 103, No. 2. pp. 105-109.
@article{e223e261bb3e449f95e6e28e98faa486,
title = "High sacrectomy for locally recurrent rectal cancer: Can long-term survival be achieved?",
abstract = "Background: Locally recurrent rectal cancer involving the upper sacrum is generally considered a contra-indication to curative surgery. The aim of this study was to determine if a survival benefit was seen in patients undergoing high sacrectomy. Methods All patients with locally recurrent rectal cancer involving the sacrum above the 3rd sacral body between 1999 and 2007 were retrospectively reviewed. Kaplan-Meier survival analysis was performed. Results Nine patients were identified with a median age of 63 years. The proximal extent of sacral resection was through S2 (n=6), S1 (n=2), and L5-S1 (n=1). All patients had R0 negative-margin resection. Median operative time was 13.7 hr, and median operative blood transfusion was 3.7 L. Thirty-day mortality was nil. Postoperative complications requiring surgical intervention occurred in three patients. Local re-recurrence in the pelvis occurred in one patient. The overall median survival was 31 months (range, 2-39 months). Three patients still alive are free of disease after 40, 76, and 101 months, respectively. Ultimately, all deaths were due to metastatic disease. Conclusions: High sacrectomy that achieves clear margins in patients with recurrent rectal cancer is safe and feasible. A majority will die of metastatic disease, but long-term survival may be possible in some patients.",
keywords = "long-term survival, recurrent rectal cancer, sacrectomy",
author = "Eric Dozois and A. Privitera and Holubar, {S. D.} and Aldrete, {J. F.} and Sim, {F. H.} and Rose, {P. S.} and Walsh, {M. F.} and Bower, {T. C.} and Leibovich, {B. C.} and Heidi Nelson and David Larson",
year = "2011",
month = "2",
doi = "10.1002/jso.21774",
language = "English (US)",
volume = "103",
pages = "105--109",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "2",

}

TY - JOUR

T1 - High sacrectomy for locally recurrent rectal cancer

T2 - Can long-term survival be achieved?

AU - Dozois, Eric

AU - Privitera, A.

AU - Holubar, S. D.

AU - Aldrete, J. F.

AU - Sim, F. H.

AU - Rose, P. S.

AU - Walsh, M. F.

AU - Bower, T. C.

AU - Leibovich, B. C.

AU - Nelson, Heidi

AU - Larson, David

PY - 2011/2

Y1 - 2011/2

N2 - Background: Locally recurrent rectal cancer involving the upper sacrum is generally considered a contra-indication to curative surgery. The aim of this study was to determine if a survival benefit was seen in patients undergoing high sacrectomy. Methods All patients with locally recurrent rectal cancer involving the sacrum above the 3rd sacral body between 1999 and 2007 were retrospectively reviewed. Kaplan-Meier survival analysis was performed. Results Nine patients were identified with a median age of 63 years. The proximal extent of sacral resection was through S2 (n=6), S1 (n=2), and L5-S1 (n=1). All patients had R0 negative-margin resection. Median operative time was 13.7 hr, and median operative blood transfusion was 3.7 L. Thirty-day mortality was nil. Postoperative complications requiring surgical intervention occurred in three patients. Local re-recurrence in the pelvis occurred in one patient. The overall median survival was 31 months (range, 2-39 months). Three patients still alive are free of disease after 40, 76, and 101 months, respectively. Ultimately, all deaths were due to metastatic disease. Conclusions: High sacrectomy that achieves clear margins in patients with recurrent rectal cancer is safe and feasible. A majority will die of metastatic disease, but long-term survival may be possible in some patients.

AB - Background: Locally recurrent rectal cancer involving the upper sacrum is generally considered a contra-indication to curative surgery. The aim of this study was to determine if a survival benefit was seen in patients undergoing high sacrectomy. Methods All patients with locally recurrent rectal cancer involving the sacrum above the 3rd sacral body between 1999 and 2007 were retrospectively reviewed. Kaplan-Meier survival analysis was performed. Results Nine patients were identified with a median age of 63 years. The proximal extent of sacral resection was through S2 (n=6), S1 (n=2), and L5-S1 (n=1). All patients had R0 negative-margin resection. Median operative time was 13.7 hr, and median operative blood transfusion was 3.7 L. Thirty-day mortality was nil. Postoperative complications requiring surgical intervention occurred in three patients. Local re-recurrence in the pelvis occurred in one patient. The overall median survival was 31 months (range, 2-39 months). Three patients still alive are free of disease after 40, 76, and 101 months, respectively. Ultimately, all deaths were due to metastatic disease. Conclusions: High sacrectomy that achieves clear margins in patients with recurrent rectal cancer is safe and feasible. A majority will die of metastatic disease, but long-term survival may be possible in some patients.

KW - long-term survival

KW - recurrent rectal cancer

KW - sacrectomy

UR - http://www.scopus.com/inward/record.url?scp=79251495108&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79251495108&partnerID=8YFLogxK

U2 - 10.1002/jso.21774

DO - 10.1002/jso.21774

M3 - Article

VL - 103

SP - 105

EP - 109

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 2

ER -